| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |